From $1 to $8? Why Analyst Experts Are Bullish on Cardiol

Sometimes stock market performance doesn’t line up with the fundamentals of a…

Aduro Clean Technologies: Analyst’s $50 Price Target Could Be Just the Beginning

Aduro Clean Technologies (NASDAQ: ADUR) (CSE: ACT) (FSE: 9D50) is gaining momentum…

Small Pharma, Big Gains: The Power of Clinical Trial Results

For smaller pharmaceutical companies, valuation can be greatly impacted by progression in…

Aduro Clean Technologies and NexGen Polymers Sign Memorandum of Understanding to Collaborate on HCT Demonstration Plant

Collaboration will support feedstock logistics, site selection and regulatory planning as Aduro…

NeuroOne® Accelerates FDA Submission for Facial Pain Treatment

NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) has announced an accelerated timeline for…